• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对撒哈拉以南非洲的抗微生物药物耐药性:当前挑战及对未来的影响。

Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.

机构信息

Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

出版信息

Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111. doi: 10.1080/14740338.2022.2106368. Epub 2022 Aug 30.

DOI:10.1080/14740338.2022.2106368
PMID:35876080
Abstract

INTRODUCTION

Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting.

AREAS COVERED

Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature.

EXPERT OPINION

All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.

摘要

简介

抗生素耐药性(AMR)令人担忧,因为这会增加发病率、死亡率和治疗成本,而撒哈拉以南非洲的 AMR 发生率居全球之首。人们对 AMR 不断上升的担忧导致了包括制定国家行动计划(NAP)在内的国际、泛非和国家层面的活动。然而,非洲各地的执行情况存在差异,主要挑战仍然存在。

涵盖领域

因此,迫切需要记录撒哈拉以南非洲目前的 NAP 活动和挑战,为未来提供指导。这是对文献进行叙述性综述的基础上进行的。

专家意见

所有接受调查的撒哈拉以南非洲国家都制定了本国的 NAP,但执行情况存在差异。博茨瓦纳和纳米比亚等国尚未正式推出 NAP,而斯威士兰最近才推出 NAP。喀麦隆在执行 NAP 方面比这些国家更为超前;尽管对执行情况存在一些担忧。南非在实施其 NAP 方面似乎迈出了最大的步伐,包括定期监测活动和发起抗菌药物管理计划。非洲各地仍然存在关键挑战。这些挑战包括开展商定的 NAP 活动所需的人员、专业知识、能力和资源,包括主动监测、缺乏推动 NAP 的协调人,以及包括捐助方在内的相互竞争的需求和优先事项。这些挑战正在得到解决,需要进一步协调努力,以减少 AMR。

相似文献

1
Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.应对撒哈拉以南非洲的抗微生物药物耐药性:当前挑战及对未来的影响。
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111. doi: 10.1080/14740338.2022.2106368. Epub 2022 Aug 30.
2
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future.非洲国家为改善医院抗菌药物使用情况所做的持续努力及其对未来的影响。
Antibiotics (Basel). 2022 Dec 15;11(12):1824. doi: 10.3390/antibiotics11121824.
3
Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications.撒哈拉以南非洲地区医院目前的抗生素使用情况;研究结果与启示
Infect Drug Resist. 2023 Apr 13;16:2179-2190. doi: 10.2147/IDR.S398223. eCollection 2023.
4
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines.应对撒哈拉以南非洲的抗菌药物耐药性:实施新的以人为本的世卫组织指南所面临的挑战和机遇。
Expert Rev Anti Infect Ther. 2024 Jun;22(6):379-386. doi: 10.1080/14787210.2024.2362270. Epub 2024 Jun 3.
5
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.巴基斯坦抗菌药物耐药性国家行动计划进展:叙述性综述及影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93. doi: 10.1080/14787210.2021.1935238. Epub 2021 Jul 26.
6
Healthcare provider-focused antimicrobial stewardship in sub-Saharan Africa: opportunities and challenges.撒哈拉以南非洲地区以医疗服务提供者为重点的抗菌药物管理:机遇与挑战
Trends Microbiol. 2023 Mar;31(3):215-218. doi: 10.1016/j.tim.2022.12.009. Epub 2023 Feb 7.
7
Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.阿根廷各利益相关者在包括动物生产系统和人类在内的抗菌药物耐药性政策方面的机遇与挑战:背景与定性分析。
BMJ Open. 2024 Jun 17;14(6):e082156. doi: 10.1136/bmjopen-2023-082156.
8
A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa.撒哈拉以南非洲地区药剂师主导的抗菌药物管理计划的系统评价。
Int J Clin Pract. 2022 Oct 13;2022:3639943. doi: 10.1155/2022/3639943. eCollection 2022.
9
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
10
Bacteriology testing and antimicrobial resistance detection capacity of national tiered laboratory networks in sub-Saharan Africa: an analysis from 14 countries.撒哈拉以南非洲国家分级实验室网络的细菌学检测及抗菌药物耐药性检测能力:来自14个国家的分析
Lancet Microbe. 2025 Jan;6(1):100976. doi: 10.1016/j.lanmic.2024.100976. Epub 2024 Dec 6.

引用本文的文献

1
One health approach unravels worrying antimicrobial resistance patterns: A cross-sectional study in Kisii, Kenya.“同一健康”方法揭示令人担忧的抗菌药物耐药模式:肯尼亚基苏木的一项横断面研究
PLoS One. 2025 Sep 3;20(9):e0331389. doi: 10.1371/journal.pone.0331389. eCollection 2025.
2
Bridging the Capacity Building Gap for Antimicrobial Stewardship Implementation: Evidence from Virtual Communities of Practice in Kenya, Ghana, and Malawi.弥合抗菌药物管理实施中的能力建设差距:来自肯尼亚、加纳和马拉维虚拟实践社区的证据。
Antibiotics (Basel). 2025 Aug 4;14(8):794. doi: 10.3390/antibiotics14080794.
3
Antibiotic Use in Pediatric Care in Ghana: A Call to Action for Stewardship in This Population.
加纳儿科护理中的抗生素使用:呼吁对这一人群进行管理的行动
Antibiotics (Basel). 2025 Aug 1;14(8):779. doi: 10.3390/antibiotics14080779.
4
Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.抗生素处方指南的全球差异及其对未来降低抗菌药物耐药性的影响。
Front Pharmacol. 2025 Aug 7;16:1600787. doi: 10.3389/fphar.2025.1600787. eCollection 2025.
5
Antimicrobial resistance to colistin in neonates: epidemiological insights and public health implications in Nigeria - a mini review.新生儿对黏菌素的耐药性:尼日利亚的流行病学见解及公共卫生影响——一篇综述
Ann Med. 2025 Dec;57(1):2536197. doi: 10.1080/07853890.2025.2536197. Epub 2025 Aug 22.
6
Progress on the Global Research Agenda for Antimicrobial Resistance in Human Health in Pakistan: Findings and Implications.巴基斯坦人类健康领域抗微生物药物耐药性全球研究议程的进展:研究结果与启示
Infect Drug Resist. 2025 Jul 29;18:3795-3828. doi: 10.2147/IDR.S531874. eCollection 2025.
7
Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications.越南社区获得性肺炎住院儿童遵守国家指南的障碍及影响
Antibiotics (Basel). 2025 Jul 15;14(7):709. doi: 10.3390/antibiotics14070709.
8
Phenotypic Detection of Extended-Spectrum β-Lactamase and Carbapenemase-Producing from Wastewater Treatment Plants in Ouagadougou, Burkina Faso.布基纳法索瓦加杜古污水处理厂产超广谱β-内酰胺酶和碳青霉烯酶细菌的表型检测
Antibiotics (Basel). 2025 Jun 25;14(7):641. doi: 10.3390/antibiotics14070641.
9
Trends and patterns of antimicrobial resistance among common pathogens isolated from adult bloodstream and urinary tract infections in public health facilities in Malawi, 2020-2024.2020 - 2024年马拉维公共卫生机构中从成人血流和尿路感染分离出的常见病原体的抗菌药物耐药性趋势和模式
BMC Infect Dis. 2025 Jul 26;25(1):946. doi: 10.1186/s12879-025-11335-1.
10
Analysis of knowledge, attitudes, and practices related to antibiotics and antimicrobial resistance awareness among community members in Ghana and Burkina Faso.加纳和布基纳法索社区成员对抗生素及抗菌药物耐药性认识的知识、态度和行为分析
Antimicrob Resist Infect Control. 2025 Jun 25;14(1):72. doi: 10.1186/s13756-025-01594-7.